Vimarsana
Biggest News Aggregation in the World

Page 3 - Statistically Significant News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Statistically Significant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Statistically Significant Today - Breaking & Trending Today

It Was My Understanding There Would Be No Math - See Also - Above the LawAbove the Law - Vimarsana News

It Was My Understanding There Would Be No Math - See Also - Above the LawAbove the Law

Statistically Significant: Elon Musk is very concerned that Twitter randomly tests .00005 percent of its population of accounts. Make sure no one tells him how polling works! He Swears On The Lives Of The Children He Remembers: Herschel Walker threatens to sue group questioning his ties to an organization that had settled with the Department of Justice to the tune $122 million. Wild And Wonderful: Guns and courtrooms don't mix. Except maybe in West Virginia. Actual Critical Race Theory: There are a lot of people complaining about "critical race theory," so Chris talked to Kimber...

No, COVID-19 Vaccines Are Not Making Periods Longer - Vimarsana News

No, COVID-19 Vaccines Are Not Making Periods Longer

A less than one-day increase in overall cycle length — not bleeding — was said to be within the normal range of fluctuations.

Source: snopes.com
Sarepta Stock Gets Mixed Reviews From Analysts - Vimarsana News

Sarepta Stock Gets Mixed Reviews From Analysts

Sarepta Therapeutics (SRPT) is under Wall Street’s microscope right now.Shares dropped by 49% in a single session last week, following the release of disappointing clinical trial results.Specifically, top-line data from the first part of the Phase 2 study evaluating SRP-9001, the company’s microdystrophin gene therapy for Duchenne muscular dystrophy (DMD) patients, failed to display a statistically significant improvement vs. the placebo.Sarepta management has explained the study’s failure was due to an imbalance in the 6-7-year-old cohort which resulted from the randomiza...

Source: yahoo.com